Born, Inc., a company originally established as Quture International, Inc. in April 2011, has released its latest Form 10-K report. The company, which aimed to revolutionize healthcare through medical software and analytics, has undergone significant changes and is currently a dormant shell exploring new business opportunities.
Financial Highlights
- Operating Expenses: $87,668,351, primarily due to administrative expenses and impairment of goodwill.
- Net Income (Loss): $(87,668,351), reflecting a substantial net loss for the year ended December 31, 2021.
- Basic and Diluted (Loss) Per Common Share: $(0.24), indicating the net loss per share for the year ended December 31, 2021.
Business Highlights
- Corporate History and Business Overview: Born, Inc., formerly Quture International, Inc., was established in April 2011 as a healthcare knowledge solution company focused on developing standards for measuring clinical performance and outcomes through medical software and analytics.
- Dormancy and Reactivation: The company was dormant from March 22, 2013, to December 26, 2019. It reactivated on December 27, 2019, when Custodian Ventures, LLC was appointed as the custodian.
- Change in Business Direction: On November 24, 2020, the company changed its name to Born, Inc. and amended its articles of incorporation to reverse split its common stock in anticipation of entering a new line of business operations.
- Share Exchange Agreement: On February 16, 2021, Born, Inc. entered into a share exchange agreement with Alkeon Creators, Inc., a UK corporation. This transaction was intended to recapitalize the company with Alkeon as the accounting acquirer. However, the transaction was voided in February 2021.
- Current Status: As of the latest report, Born, Inc. is a dormant shell company with no operations or revenue. The company is exploring business opportunities within the U.S., including potential acquisitions through reverse mergers or similar transactions.
- Future Outlook: Management intends to explore and identify viable business opportunities within the U.S., including seeking to acquire a business in a reverse merger. The company plans to fund its working capital requirements through existing funds and future issuances of debt or equity securities.
Strategic Initiatives
- Debt Reduction: The company is focused on improving its liquidity and financial stability by reducing outstanding debt by $200 million as part of a broader strategy to enhance financial health and operational efficiency.
- Capital Expenditures: Plans for new capital expenditures aimed at expanding manufacturing capabilities and supporting long-term growth have been announced.
- Share Repurchase Program: The company has actively engaged in share repurchase activities, buying back $50 million of its own shares under the authorized buyback program to return value to shareholders and optimize the capital structure.
- Dividend Increase: The company has increased its quarterly dividend by 5%, reflecting confidence in ongoing cash flow generation and commitment to providing shareholder returns.
- Future Outlook: Looking ahead, the company plans to maintain its focus on debt reduction and prudent capital management. It aims to explore new opportunities for capital investment, particularly in areas that align with sustainable growth initiatives. The company is also committed to enhancing shareholder value through continued dividend growth and strategic share repurchases.
Challenges and Risks
- Supplier Dependency: The company's reliance on a single supplier for key raw materials presents a significant risk. This dependency could lead to supply chain disruptions, increased costs, or inability to meet customer demand if the supplier faces operational issues or decides to alter terms of supply.
- Dormant Status: As a dormant shell with no operations or revenue, the company faces significant operational risk. Management is exploring business opportunities, including potential acquisitions through reverse mergers, but there is no assurance of success. The lack of diversification in potential business combinations increases the risk of financial instability.
- Pandemic Impact: The ongoing effects of the coronavirus pandemic present additional uncertainties, potentially hindering the identification and implementation of viable business strategies. The company anticipates incurring operating losses in the next 12 months due to costs related to SEC reporting obligations and potential business combinations.
- Capital Requirements: Management acknowledges the need for additional capital to fund operations and potential acquisitions. However, there is uncertainty regarding the availability of such capital on acceptable terms, which could restrict business operations and growth opportunities.
SEC Filing: